Vanguard Portfolio Management
FOLD

Vanguard Portfolio Management’s Amicus Therapeutics FOLD Stock Holding History

Vanguard Portfolio Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,974,932
Closed -$202M – 3181
2026
Q1 		$202M Buy
+13,974,932
New +$200M 0.01% 1144

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Vanguard Portfolio Management's FOLD Position: Q2 2026 in Review

Vanguard Portfolio Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 13,974,932 shares — an estimated $202M sold.

Vanguard Portfolio Management first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $202M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Vanguard Portfolio Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Vanguard Portfolio Management sold 13,974,932 Amicus Therapeutics shares in Q2 2026, an estimated $202M.
  • Vanguard Portfolio Management first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
  • Vanguard Portfolio Management's Amicus Therapeutics position peaked at $202M in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.